The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,988.00
Bid: 12,016.00
Ask: 12,020.00
Change: -38.00 (-0.32%)
Spread: 4.00 (0.033%)
Open: 12,070.00
High: 12,144.00
Low: 11,882.00
Prev. Close: 12,026.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 rises after BoE's new rescue measures, midcaps stuck in the red

Thu, 19th Mar 2020 10:48

* FTSE bounces after BoE eases again

* Recent sterling slide helps exporters, banks also gain

* Joules, Playtech, Crest Nicholson scrap dividend

* FTSE 100 up 1.4%, FTSE 250 down 1.4%
(Updates with closing prices)

By Sruthi Shankar

March 19 (Reuters) - Britain's top shares ended a volatile
session higher on Thursday after the Bank of England cut
interest rates to a record low and ramped up its bond-buying
programme in a bid to rescue the economy from the coronavirus
crisis.

After wild swings earlier in the day, the blue-chip FTSE 100
rose 1.4%, with big dollar earners such as Diageo
, Royal Dutch Shell and AstraZeneca
providing the biggest boost, even as the pound recovered from a
35-year low.

The central bank cut interest rates to 0.1%, its second
emergency rate cut in just over a week, and promised 200 billion
pounds of additional bond purchases, and at a much faster pace
than normal.

The moves follow similar drastic measures by other central
banks and governments, including a 330 billion-pound stimulus
package from the UK government earlier this week, to inject
liquidity into markets and stem an economic slowdown, which many
fear may have already pushed the global economy into a short
slump.

"We would not be surprised if the BoE's announcement
prepares the ground for more fiscal announcements soon,"
Citigroup's Christian Schulz wrote in a note.

"We expect further programmes to absorb households' income
losses due to the COVID-19 crisis and eventually also stimulus
and debt forgiveness for companies."

The announcement, however, failed to pull midcap stocks out
of their misery. The FTSE Mid 250 index dropped 1.4% for
its eleventh day of losses after Prime Minister Boris Johnson
enforced tougher measures to contain the virus.

"This (stimulus measures) will help at the margin,
particularly the fiscal spend, if they can find a way to get the
money to businesses and individuals," a fund manager at a UK-
based asset manager said.

"For confidence to meaningfully turn more positive, we need
to see the rate of infection slow in Western markets."

Shares in homebuilder Crest Nicholson slumped 30%
after it cancelled payment of its final dividend along with
financial forecasts for 2020.

Fashion retailer Joules Group and gambling software
maker Playtech also announced similar measures.

A leading ventilator manufacturer, Hamilton Medical, told
Reuters that Britain faces a "massive shortage" of the
ventilators that will be needed to treat critically ill patients
suffering from coronavirus.

Luxury brand Burberry Group warned that sales in
the final weeks of March would plunge by around 70% to 80%
compared to last year.

Pub operator Young & Co's Brewery Plc fell 5.2%
after it said that the closure of some or all of its pubs for at
least a short period was "imminent".

Next rose 5.3% after the clothing retailer said it
could sustain a hit from the coronavirus outbreak of more than 1
billion pounds ($1.2 billion) without exceeding its debt and
bank facilities.
(Reporting by Sruthi Shankar and Devik Jain in Bengaluru;
Editing by Bernard Orr, Saumyadeb Chakrabarty, Kirsten Donovan)

More News
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.